Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CBLLthis companyCeriBell, Inc.	$27.25	-15.02×	5.16×	9×	-15.61×	-258.3%	87.9%	-65.6%	-60.0%	-34.4%	-32.9%	-5.2%	0.14×	0.36×	-30.9×	9.73×	0.0%	2	14.49	2	C+
CVRXCVRx, Inc.	$0.93	-3.48×	4.71×	3.27×	-3.43×	-11723.2%	85.3%	-90.5%	-94.1%	-135.6%	-56.0%	-22.0%	1.29×	0.53×	-8.8×	7.63×	0.0%	3	-9.03	1	D+
ECORelectroCore, Inc.	$7.26	-2.72×	-22.29×	1.19×	-3.46×	-4106.2%	86.8%	-41.1%	-43.6%	817.2%	-171.0%	-21.7%	-5.5×	-0.2×	-22.29×	1.02×	0.0%	3	-14.75	2	C
NMTCNeuroOne Medical Technologies Corporation	$0.90	-9.87×	5.04×	2.95×	-9.76×	-18014.5%	67.3%	-34.9%	-29.8%	-51.0%	-49.1%	-8.2%	0.04×	2.09×	-12.65×	4.44×	0.0%	3	-18.47	1	C-
NPCENeuroPace, Inc.	$13.03	-23.39×	26.55×	5.05×	-45.97×	-358.6%	77.2%	-16.3%	-21.5%	-112.8%	-18.2%	-2.2%	3.72×	-4.08×	-2.19×	5.28×	0.0%	3	-3.76	1	D+
STIMNeuronetics, Inc.	$2.22	-2.34×	4.07×	0.61×	-5.43×	-2342.1%	48.5%	-21.1%	-26.1%	-174.3%	-27.0%	-23.3%	4.04×	-2.07×	-3.74×	2.02×	0.0%	3	-3.35	2	C
Peer median	—	-3.48×	4.71×	2.95×	-5.43×	-4106.2%	77.2%	-34.9%	-29.8%	-112.8%	-49.1%	-21.7%	1.29×	-0.2×	-8.8×	4.44×	0.0%	3	-9.03	1	—